HCAT · XBRL financial data

Health Catalyst financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (HCAT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	189	242	276	296	307	311
Research and development	54	63	76	73	58	50
General and administrative	59	86	62	77	57	50
Total operating expenses	187	261	273	259	211	313
Operating income (loss)	(96)	(144)	(140)	(127)	(70)	(161)
Income tax expense (benefit)	(1)	(7)	(4)	0	0	1
Net income (loss)	(115)	(153)	(137)	(118)	(70)	(178)
Earnings per share, basic USD per share	(2.91)	(3.23)	(2.56)	(2.09)	(1.15)	(2.55)
Earnings per share, diluted USD per share	(2.91)	(3.23)	(2.63)	(2.09)	(1.15)	(2.55)
Weighted average shares, basic millions of shares	40	47	54	56	60	70
Weighted average shares, diluted millions of shares	40	47	54	56	60	70

Fiscal years (HCAT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	92	193	116	106	250	51
Short-term investments	179	252	247	211	142	45
Accounts receivable	48	49	48	60	57	59
Prepaid and other current assets	11	15	16	15	16	14
Total current assets	330	508	428	393	466	169
Property and equipment, net	13	23	26	26	29	34
Right-of-use asset	25	21	17	14	12	7
Goodwill	108	170	186	191	260	209
Total assets	578	832	752	702	859	503
Accounts payable	5	5	4	7	11	9
Current portion of long-term debt	—	—	—	0	231	2
Total current liabilities	88	93	83	89	326	90
Long-term debt	169	181	227	228	151	152
Lease liability, non-current	24	20	18	18	16	14
Total liabilities	302	310	327	335	494	257
Accumulated deficit	(726)	(879)	(999)	(1,117)	(1,187)	(1,365)
Total stockholders' equity	276	522	425	367	365	246
Total liabilities and equity	578	832	752	702	859	503
Common shares outstanding (cover page) millions of shares	44	53	56	59	70	74

Fiscal years (HCAT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(115)	(153)	(137)	(118)	(70)	(178)
Stock-based compensation	38	65	72	56	40	27
Net cash from operating activities	(26)	(23)	(35)	(33)	15	1
Purchases of property and equipment	8	10	2	1	2	1
Net cash from investing activities	(83)	(140)	(39)	20	(23)	36
Proceeds from issuing common stock	0	245	0	0	—	—
Share repurchases	0	0	8	2	0	5
Proceeds from long-term debt	—	—	—	0	152	0
Net cash from financing activities	183	264	(3)	3	152	(236)
Net change in cash	74	101	(77)	(10)	143	(199)

SIC 7370 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 7370 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Health Catalyst	61	70	0.3*	75.3M	—	Q2 FY26 10-QJun 30, 2026
Neutron Holdings	278	304	not reported	65.0M	—	Q2 FY26 10-QJun 30, 2026
Ooma	18	83	13*	27.6M	—	Q2 FY27 10-QJul 31, 2026
Kaltura	26	47	(2)*	152.6M	16.0 quarters	Q2 FY26 10-QJun 30, 2026
Asure Software	17	40	5.6*	30.2M	—	Q3 FY26 10-QSep 30, 2026
TruBridge	35	86	15	15.0M	—	Q1 FY26 10-QMar 31, 2026
Backblaze	189	47	9*	63.2M	—	Q3 FY26 10-QSep 30, 2026
8X8	91	190	17	144.4M	—	Q1 FY27 10-QJun 30, 2026
TaskUs	180	309	43*	not reported	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.